TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached.
4imprint Group PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Details of person subject to the notification obligation
Name
Kames Capital Plc
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.)
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached :
07/04/2020
6. Date on which issuer notified (DD/MM/YYYY):
09/04/2020
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached
3.33%
0.03%
3.36%
28,085,530
Position of previous notification (if
applicable)
2.83%
0.03%
2.86%
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
Number of voting rights
% of voting rights
Class/type of
shares
ISIN code (if possible)
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0006640972
410,344
526,092
1.46%
1.87%
SUBTOTAL 8. A
936,436
3.33%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument
Expiration
date
Exercise/
Conversion Period
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument
Expiration
date
Exercise/
Conversion Period
Physical or cash
settlement
Number of voting rights
% of voting rights
CFD
9,049
0.03%
SUBTOTAL 8.B.2
9,049
0.03%
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
X
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)
Name
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial in-struments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Kames Capital:-
Kames Capital Plc
Kames Capital ICVC
Kames Capital VCIC
10. In case of proxy voting, please identify:
Name of the proxy holder
Kames Capital Plc
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information
Kames Capital plc acquires holdings as agent and discretionary manager for underlying clients including: UCITS funds, other collective investment schemes and segregated, institutional clients. Exercise of voting rights is controlled by Kames Capital plc.
Place of completion
Edinburgh, Scotland, United Kingdom
Date of completion
08 April 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.